FDA releases hold on second of Intellia’s ATTR-CM gene therapy trials
Two Phase III trials were put on clinical hold by the FDA in October 2025.
03 March 2026
03 March 2026
Two Phase III trials were put on clinical hold by the FDA in October 2025.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.